U.S. markets closed


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
32.10+5.34 (+19.96%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close26.76
Bid32.21 x 800
Ask32.01 x 900
Day's Range28.73 - 32.71
52 Week Range12.29 - 32.71
Avg. Volume942,173
Market Cap2.307B
Beta (5Y Monthly)2.16
PE Ratio (TTM)N/A
EPS (TTM)-9.55
Earnings DateJul 28, 2021 - Aug 02, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-40% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Mednax Inc (MD) Q1 2021 Earnings Call Transcript
    Motley Fool

    Mednax Inc (MD) Q1 2021 Earnings Call Transcript

    With me today are Mark Ordan, our CEO; and Mark Richards, our CFO. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.

  • Why Mednax Stock Is Soaring Today
    Motley Fool

    Why Mednax Stock Is Soaring Today

    What happened Shares of Mednax (NYSE: MD) were soaring 16.3% higher at 11:56 a.m. EDT on Friday. The big gain came after the company announced its first-quarter results before the market opened. So what Mednax reported net revenue in the first quarter of $446.

  • Mednax (MD) Q1 Earnings and Revenues Beat Estimates

    Mednax (MD) Q1 Earnings and Revenues Beat Estimates

    Mednax (MD) delivered earnings and revenue surprises of 60.00% and 2.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?